Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device
12 févr. 2018 09h32 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™...
Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction
01 févr. 2018 09h32 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™...
Endonovo Announces First Commercial Sales for SofPulse Wearable Electroceutical for Post-Operative Pain and Edema
22 janv. 2018 07h00 HE
|
Endonovo Therapeutics, Inc.
Seeking Distribution Partners in Europe for CE-Marked Electroceutical™ Device for Promotion of Wound Healing, Reduction of Pain and Post-Operative Edema LOS ANGELES, CA, Jan. 22, 2018 (GLOBE...
Endonovo Therapeutics Provides Corporate Update and 2018 Outlook
16 janv. 2018 09h35 HE
|
Endonovo Therapeutics, Inc.
- Announces Series C Preferred Stock Offering - Updates Status of Clinical Pipeline in Central Nervous System Disorders LOS ANGELES, CA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- - Endonovo...
Endonovo Therapeutics Engages ShareIntel, A Leader In Shareholder Intelligence Services To Investigate Market Maker and Clearing Firm Irregularities
11 janv. 2018 09h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a clinical-stage developer of non-invasive electroceuticals for the...
Endonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical Study
28 déc. 2017 09h30 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a clinical-stage developer of non-invasive electroceuticals for the...
Endonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles Lawsuit
26 déc. 2017 07h30 HE
|
Endonovo Therapeutics, Inc.
Endonovo to Fund All Currently Planned and Future Clinical Trials for Traumatic Brain Injury, Post-Concussion Syndrome, Stroke and Other Central Nervous System Disorders LOS ANGELES, CA, Dec. ...
Endonovo Therapeutics Files Continuation Patent for Producing Adult Stem Cell Secretome
29 juin 2016 09h32 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(Marketwired - Jun 29, 2016) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a developer of bioelectronic devices and medicines, announced today that it...
Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA Regulatory Pathway for Urinary Incontinence Treatment
02 déc. 2014 09h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(Marketwired - Dec 2, 2014) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a biotechnology company developing innovative regenerative therapies, has...
Endonovo Therapeutics Files Patent on Bioelectronic Technology, Devices and Therapies
02 sept. 2014 09h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(Marketwired - Sep 2, 2014) - Endonovo Therapeutics, Inc. (OTCQB: ENDV), a developer of novel cell-free therapies, announced today that it has filed a patent on bioelectronic...